首页 > 最新文献

International Journal of Immunopathology and Pharmacology最新文献

英文 中文
PD-L1 expression in breast invasive ductal carcinoma with incomplete pathological response to neoadjuvant chemotherapy PD-L1在新辅助化疗不完全病理反应的乳腺浸润性导管癌中的表达
IF 3.5 3区 医学 Q3 IMMUNOLOGY Pub Date : 2022-01-01 DOI: 10.1177/03946320221078433
Ahmad Alhesa, Heyam A. Awad, Sarah Bloukh, Mahmoud Al-Balas, Mohammed El-Sadoni, Duaa Qattan, Bilal Azab, T. Saleh
Objectives: To investigate the expression of programmed death-ligand 1 (PD-L1) in breast cancer in association with incomplete pathological response (PR) to neoadjuvant chemotherapy (NAC). Methods PD-L1 expression was evaluated using immunohistochemistry in post-operative, post-NAC samples of 60 patients (n = 60) diagnosed with breast invasive ductal carcinoma with incomplete PR to NAC, including 31 matched pre-NAC and post-NAC samples (n = 31). PD-L1 protein expression was assessed using three scoring approaches, including the tumor proportion score (TPS), the immune cell score (ICS), and the combined tumor and immune cell score (combined positive score, CPS) with a 1% cut-off. Results In the post-operative, post-NAC samples (n = 60), positive expression rate of PD-L1 was observed in 18.3% (11/60) of cases by TPS, 31.7% (19/60) by ICS, and 25% (15/60) by CPS. In matched samples, positive expression rate of PD-L1 was observed in 19.3% (6/31) of patients by TPS, 51.6% (16/31) by ICS, and 19.3% (6/31) by CPS in pre-NAC specimens, while it was observed in 22.6% (7/31) of matched post-NAC samples by TPS, 22.6% (7/31) by ICS, and 19.3% (6/31) by CPS. In the matched samples, there was a significant decrease in PD-L1 immunoexpression using ICS in post-NAC specimens (McNemar’s, p = 0.020), while no significant differences were found using TPS and CPS between pre- and post-NAC samples (p = 1.000, p = 0.617; respectively). PD-L1 immunoexpression determined by TPS or CPS was only significantly associated with ER status (p = 0.022, p = 0.021; respectively), but not with other clinicopathological variables. We could not establish a correlation between PD-L1 expression and the overall survival rate (p > 0.05). There were no significant differences in the tumor infiltrating lymphocytes count between the paired pre- and post-NAC samples (t = 0.581, p = 0.563 or Wilcoxon’s Signed Rank test; z = -0.625, p = 0.529). Conclusion Our findings indicate that PD-L1 protein expression in infiltrating immune cells was significantly reduced in breast tumors that developed incomplete PR following the exposure to NAC.
目的:探讨程序性死亡配体1(PD-L1)在癌症中的表达与新辅助化疗不完全病理反应(PR)的关系。方法应用免疫组织化学方法对60例(n=60)诊断为乳腺浸润性导管癌伴不完全PR至NAC的患者术后、NAC后样本中PD-L1的表达进行评估,包括31例匹配的NAC前后样本(n=31)。使用三种评分方法评估PD-L1蛋白表达,包括肿瘤比例评分(TPS)、免疫细胞评分(ICS)和肿瘤和免疫细胞综合评分(阳性综合评分,CPS),截止值为1%。结果在术后NAC后样本(n=60)中,TPS、ICS和CPS的PD-L1阳性表达率分别为18.3%(11/60)、31.7%(19/60)和25%(15/60)。在匹配样本中,在NAC前样本中,通过TPS、ICS和CPS分别在19.3%(6/31)、51.6%(16/31)和19.3%(6/11)的患者中观察到PD-L1的阳性表达率,而通过TPS、ICS22.6%(7/31)和CPS在22.6%(6/31。在匹配的样本中,使用ICS的PD-L1免疫表达在NAC后样本中显著降低(McNemar’s,p=0.020),而使用TPS和CPS的PD-L1在NAC前和NAC后样品之间没有发现显著差异(分别为p=1.000,p=0.617)。TPS或CPS测定的PD-L1免疫表达仅与ER状态显著相关(分别为p=0.022,p=0.021),而与其他临床病理变量无关。我们不能确定PD-L1表达与总生存率之间的相关性(p>0.05)。NAC前后配对的肿瘤浸润淋巴细胞计数没有显著差异(t=0.581,p=0.563或Wilcoxon符号秩检验;z=-0.625,p=0.529)在暴露于NAC后出现不完全PR的乳腺肿瘤中,细胞显著减少。
{"title":"PD-L1 expression in breast invasive ductal carcinoma with incomplete pathological response to neoadjuvant chemotherapy","authors":"Ahmad Alhesa, Heyam A. Awad, Sarah Bloukh, Mahmoud Al-Balas, Mohammed El-Sadoni, Duaa Qattan, Bilal Azab, T. Saleh","doi":"10.1177/03946320221078433","DOIUrl":"https://doi.org/10.1177/03946320221078433","url":null,"abstract":"Objectives: To investigate the expression of programmed death-ligand 1 (PD-L1) in breast cancer in association with incomplete pathological response (PR) to neoadjuvant chemotherapy (NAC). Methods PD-L1 expression was evaluated using immunohistochemistry in post-operative, post-NAC samples of 60 patients (n = 60) diagnosed with breast invasive ductal carcinoma with incomplete PR to NAC, including 31 matched pre-NAC and post-NAC samples (n = 31). PD-L1 protein expression was assessed using three scoring approaches, including the tumor proportion score (TPS), the immune cell score (ICS), and the combined tumor and immune cell score (combined positive score, CPS) with a 1% cut-off. Results In the post-operative, post-NAC samples (n = 60), positive expression rate of PD-L1 was observed in 18.3% (11/60) of cases by TPS, 31.7% (19/60) by ICS, and 25% (15/60) by CPS. In matched samples, positive expression rate of PD-L1 was observed in 19.3% (6/31) of patients by TPS, 51.6% (16/31) by ICS, and 19.3% (6/31) by CPS in pre-NAC specimens, while it was observed in 22.6% (7/31) of matched post-NAC samples by TPS, 22.6% (7/31) by ICS, and 19.3% (6/31) by CPS. In the matched samples, there was a significant decrease in PD-L1 immunoexpression using ICS in post-NAC specimens (McNemar’s, p = 0.020), while no significant differences were found using TPS and CPS between pre- and post-NAC samples (p = 1.000, p = 0.617; respectively). PD-L1 immunoexpression determined by TPS or CPS was only significantly associated with ER status (p = 0.022, p = 0.021; respectively), but not with other clinicopathological variables. We could not establish a correlation between PD-L1 expression and the overall survival rate (p > 0.05). There were no significant differences in the tumor infiltrating lymphocytes count between the paired pre- and post-NAC samples (t = 0.581, p = 0.563 or Wilcoxon’s Signed Rank test; z = -0.625, p = 0.529). Conclusion Our findings indicate that PD-L1 protein expression in infiltrating immune cells was significantly reduced in breast tumors that developed incomplete PR following the exposure to NAC.","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44242925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Elevated number of IL-21+ TFH and CD86+CD38+ B cells in blood of renal transplant recipients with AMR under conventional immuno-suppression. 在常规免疫抑制下,患有 AMR 的肾移植受者血液中 IL-21+ TFH 和 CD86+CD38+ B 细胞数量升高。
IF 3 3区 医学 Q3 IMMUNOLOGY Pub Date : 2022-01-01 DOI: 10.1177/20587384211048027
Jing Liu, Tongyu Tang, Zhihui Qu, Li Wang, Rui Si, Haifeng Wang, Yanfang Jiang

The objective of this study is to detect the number of different subsets of TFH and B cells in renal transplant recipients (RTR) with antibody-mediated acute rejection (AMR), acute rejection (AR), chronic rejection (CR), or transplant stable (TS). The present study was a prospective study. The numbers of ICOS +, PD-1+ and IL-21+ TFH, CD86+, CD38+, CD27+, and IgD- B cells in 21 patients with end-stage renal disease (ESRD) and post-transplant times were measured by flow cytometry. The level of serum IL-21 was detected by ELISA. The numbers of circulating CD4+CXCR5+, CD4+CXCR5+ICOS+, CD4+CXCR5+PD-1+, CD4+CXCR5+IL-21+ TFH, CD19+CD86+, and CD19 +CD86+CD38+ B cells as well as the level of serum IL-21 in the AMR, AR, and CR groups at post-transplantation were significantly higher than those at pre-transplantation. In contrast, the number of circulating CD19+CD27+IgD B cells was significantly increased in the TS groups in respect to the other groups. Moreover, the numbers of circulating CD4+CXCR5+IL-21+ TFH cells, CD19+CD86+CD38+ B cells as well as the level of serum IL-21 were positive related to the level of serum Cr while showing negative correlated with the values of eGFR in the AMR groups at post-transplantation for 4 and 12 weeks. Circulating TFH cells may be a biomarker in RTR with AMR, which can promote the differentiation of B cells into plasma cells by activating B cells, thereby promoting disease progression.

本研究的目的是检测存在抗体介导的急性排斥反应(AMR)、急性排斥反应(AR)、慢性排斥反应(CR)或移植稳定(TS)的肾移植受者(RTR)中 TFH 和 B 细胞不同亚群的数量。本研究是一项前瞻性研究。通过流式细胞术测量了21例终末期肾病(ESRD)患者的ICOS+、PD-1+和IL-21+ TFH、CD86+、CD38+、CD27+和IgD- B细胞的数量以及移植后的时间。血清中 IL-21 的水平通过 ELISA 检测。AMR组、AR组和CR组移植后循环CD4+CXCR5+、CD4+CXCR5+ICOS+、CD4+CXCR5+PD-1+、CD4+CXCR5+IL-21+ TFH、CD19+CD86+和CD19+CD86+CD38+ B细胞的数量以及血清IL-21的水平均显著高于移植前。相比之下,TS 组循环 CD19+CD27+IgD B 细胞的数量明显高于其他组。此外,在移植后4周和12周,AMR组的循环CD4+CXCR5+IL-21+ TFH细胞、CD19+CD86+CD38+ B细胞数量以及血清IL-21水平与血清Cr水平呈正相关,而与eGFR值呈负相关。循环中的TFH细胞可能是RTR合并AMR的生物标志物,可通过激活B细胞促进B细胞分化为浆细胞,从而促进疾病进展。
{"title":"Elevated number of IL-21+ TFH and CD86+CD38+ B cells in blood of renal transplant recipients with AMR under conventional immuno-suppression.","authors":"Jing Liu, Tongyu Tang, Zhihui Qu, Li Wang, Rui Si, Haifeng Wang, Yanfang Jiang","doi":"10.1177/20587384211048027","DOIUrl":"10.1177/20587384211048027","url":null,"abstract":"<p><p>The objective of this study is to detect the number of different subsets of TFH and B cells in renal transplant recipients (RTR) with antibody-mediated acute rejection (AMR), acute rejection (AR), chronic rejection (CR), or transplant stable (TS). The present study was a prospective study. The numbers of ICOS +, PD-1+ and IL-21+ TFH, CD86+, CD38+, CD27+, and IgD- B cells in 21 patients with end-stage renal disease (ESRD) and post-transplant times were measured by flow cytometry. The level of serum IL-21 was detected by ELISA. The numbers of circulating CD4+CXCR5+, CD4+CXCR5+ICOS+, CD4+CXCR5+PD-1+, CD4+CXCR5+IL-21+ TFH, CD19+CD86+, and CD19 +CD86+CD38+ B cells as well as the level of serum IL-21 in the AMR, AR, and CR groups at post-transplantation were significantly higher than those at pre-transplantation. In contrast, the number of circulating CD19+CD27+IgD B cells was significantly increased in the TS groups in respect to the other groups. Moreover, the numbers of circulating CD4+CXCR5+IL-21+ TFH cells, CD19+CD86+CD38+ B cells as well as the level of serum IL-21 were positive related to the level of serum Cr while showing negative correlated with the values of eGFR in the AMR groups at post-transplantation for 4 and 12 weeks. Circulating TFH cells may be a biomarker in RTR with AMR, which can promote the differentiation of B cells into plasma cells by activating B cells, thereby promoting disease progression.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"36 ","pages":"20587384211048027"},"PeriodicalIF":3.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/76/50/10.1177_20587384211048027.PMC8755922.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39897235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abnormal sperm morphology is associated with sensitization to inhaled allergens. 精子形态异常与吸入过敏原致敏有关。
IF 3.5 3区 医学 Q3 IMMUNOLOGY Pub Date : 2022-01-01 DOI: 10.1177/20587384211066718
Rafał Adamczak, Natalia Ukleja-Sokołowska, Magdalena Pasińska, Joanna Zielińska, Mateusz Leśny, Mariusz Dubiel

Background: Allergy is associated with the loss of tolerance of environmental antigens, combined with a pathological immune response. There were no studies up to date that would show whether the quality of semen decreases in people with allergic diseases.

Material and methods: The research included men who reported to the Gynecological Outpatient Clinic due to reproductive difficulties, defined as the lack of pregnancy after one year of regular intercourse. Semen quality was assessed according to the World Health Organization (WHO) standard. All patients underwent skin prick tests with the most important inhalation allergens (such as hazel, silver birch, mugwort, rye, dog, cat, Dermatophagoides farinae, Dermatophagoides pteronyssinus, alder, Alternaria alternata, Cladosporium herbarum, and grass mix). The data was statistically analyzed.

Results: Results of 52 patients aged 25-52 years (34.62 ± 4.96) were analyzed. The mean BMI (Body mass index) was 28.25 (+ -3.77). It was found that 38 men (73%) had increased body weight, and 14 men (26.9%) were obese (BMI > = 30). 13 patients were smokers (25%), and 24 patients (46%) had skin tests positive for at least one inhaled allergen. Sperm tail defects were statistically more significant in patients allergic to birch, rye, cat, alder, and grass. In patients allergic to Alternaria alternata, head defects were statistically more significant (p < .05). No association was found between allergy to house dust mites, mugwort, hazel, and dogs and the deterioration of semen.

Conclusion: Allergy due to inhalation allergens had an influence on the quality of male semen. Further research is necessary to establish the immunological bases of this phenomenon.

背景:过敏与环境抗原耐受性的丧失有关,并伴有病理性免疫反应。目前还没有研究表明患有过敏性疾病的人精液质量是否会下降。材料和方法:该研究包括因生殖困难(定义为在一年的正常性交后没有怀孕)而到妇科门诊就诊的男性。精液质量按世界卫生组织(WHO)标准评定。所有患者均行皮肤点刺试验,其中包括最重要的吸入性过敏原(如榛子、白桦、艾草、黑麦、狗、猫、粉棘棘球蚴、翼状棘球蚴、桤木、交替棘球蚴、草本棘球蚴和草混合物)。对数据进行统计学分析。结果:分析25 ~ 52岁患者52例(34.62±4.96)。平均BMI(身体质量指数)为28.25(±3.77)。结果发现体重增加38例(73%),肥胖14例(26.9%)(BMI > = 30)。13名患者是吸烟者(25%),24名患者(46%)的皮肤试验至少对一种吸入过敏原呈阳性。在对桦树、黑麦、猫、桤木和草过敏的患者中,精子尾部缺陷在统计上更为显著。在对互花草过敏的患者中,头部缺陷的发生率有统计学意义(p < 0.05)。没有发现对室内尘螨、艾草、榛子和狗过敏与精液恶化之间的联系。结论:吸入性变应原对男性精液质量有影响。需要进一步的研究来确定这一现象的免疫学基础。
{"title":"Abnormal sperm morphology is associated with sensitization to inhaled allergens.","authors":"Rafał Adamczak,&nbsp;Natalia Ukleja-Sokołowska,&nbsp;Magdalena Pasińska,&nbsp;Joanna Zielińska,&nbsp;Mateusz Leśny,&nbsp;Mariusz Dubiel","doi":"10.1177/20587384211066718","DOIUrl":"https://doi.org/10.1177/20587384211066718","url":null,"abstract":"<p><strong>Background: </strong>Allergy is associated with the loss of tolerance of environmental antigens, combined with a pathological immune response. There were no studies up to date that would show whether the quality of semen decreases in people with allergic diseases.</p><p><strong>Material and methods: </strong>The research included men who reported to the Gynecological Outpatient Clinic due to reproductive difficulties, defined as the lack of pregnancy after one year of regular intercourse. Semen quality was assessed according to the World Health Organization (WHO) standard. All patients underwent skin prick tests with the most important inhalation allergens (such as hazel, silver birch, mugwort, rye, dog, cat, <i>Dermatophagoides farinae, Dermatophagoides pteronyssinus</i>, alder, <i>Alternaria alternata, Cladosporium herbarum</i>, and grass mix). The data was statistically analyzed.</p><p><strong>Results: </strong>Results of 52 patients aged 25-52 years (34.62 ± 4.96) were analyzed. The mean BMI (Body mass index) was 28.25 (+ -3.77). It was found that 38 men (73%) had increased body weight, and 14 men (26.9%) were obese (BMI > = 30). 13 patients were smokers (25%), and 24 patients (46%) had skin tests positive for at least one inhaled allergen. Sperm tail defects were statistically more significant in patients allergic to birch, rye, cat, alder, and grass. In patients allergic to <i>Alternaria alternata</i>, head defects were statistically more significant (<i>p</i> < .05). No association was found between allergy to house dust mites, mugwort, hazel, and dogs and the deterioration of semen.</p><p><strong>Conclusion: </strong>Allergy due to inhalation allergens had an influence on the quality of male semen. Further research is necessary to establish the immunological bases of this phenomenon.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"36 ","pages":"20587384211066718"},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9c/7a/10.1177_20587384211066718.PMC8743921.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39647129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens 白细胞介素-4的单核苷酸多态性rs 2070874与1型糖尿病风险增加相关,与人类白细胞抗原无关
IF 3.5 3区 医学 Q3 IMMUNOLOGY Pub Date : 2022-01-01 DOI: 10.1177/03946320221090330
A. Osman, I. Brema, Alaa AlQurashi, A. Al-jurayyan, Benjamin Bradley, Muaawia Hamza
Introduction Type 1 diabetes mellitus (T1DM) is characterized by autoimmune destruction of insulin-producing pancreatic beta (β-) cells. Previous studies suggested an imbalance between and pro- and anti-inflammatory cytokines exacerbates T1DM development. Objectives We aimed to test the hypothesis that patients with T1DM carry a higher frequency of regulatory genes associated with low levels of the anti-inflammatory cytokines interleukin-4 (IL-4), its receptor (IL-4R), and interleukin-10 (IL-10). Methods Accordingly, we compared frequencies of five different single nucleotide polymorphisms (SNPs) in T1DM patients and healthy controls who had been typed for HLA-DRB1, HLA-DQA1, and HLA-DQB1 genes. Results The frequencies of rs2070874 (IL-4) alleles C and T differed between T1DM patients and controls (cp = 0.0065), as did their codominant (cp = 0.026) and recessive (cp = 0.015) models. Increased frequencies were observed in T1DM patients for HLA alleles: DRB1*03 (pc < 0.0013), DRB1*04 (cp = 0.0169), DQA1*03 (cp = 0.0222), DQA1*05 (cp < 0.0006), DQB1*02 (cp = 0.0005), and DQB1*06 (cp < 0.0005). And lower frequencies were observed for: DRB1*07 (cp = 0.0078), DRB1*11 (cp = 0.0013), DRB1*13 (cp < 0.0364), DRB1*15 (cp < 0.0013), DQA1*01 (cp < 0.0006), and DQA1*02 (cp = 0.0348). Certain DRB1: DQA1: DQB1 haplotypes showed greater frequencies, including, 03:05:02 (p < 0.0001) and 04:03:03 (p = 0.0017), whereas others showed lower frequencies, including, 07:02:02 (p = 0.0032), 11:05:03 (p = 0.0007), and 15:01:06 (p = 0.0002). Stratification for the above HLA haplotypes with rs2070874 C/C exhibited no significant differences between T1DM patients overall and controls. However, when stratified for the vulnerable HLA haplotype (03:05:02/04:03:03), young patients in whom T1DM began at ≤13 years had a higher frequency of the SNP (rs2070874 C/C); a gene associated with low IL-4 production (p < 0.024). Conclusion This study suggests that possession of the rs2070874 C/C genotype, which is associated with low production of IL-4, increases the risk of T1DM in young individuals carrying vulnerable HLA alleles/haplotypes.
1型糖尿病(T1DM)的特点是自身免疫破坏产生胰岛素的胰腺β (β-)细胞。先前的研究表明,促炎性和抗炎性细胞因子之间的失衡会加剧T1DM的发展。我们的目的是验证T1DM患者携带与低水平抗炎细胞因子白介素-4 (IL-4)、其受体(IL-4R)和白介素-10 (IL-10)相关的调控基因频率较高的假设。方法比较了HLA-DRB1、HLA-DQA1和HLA-DQB1基因分型的T1DM患者和健康对照者5种不同单核苷酸多态性(snp)的频率。结果rs2070874 (IL-4)等位基因C和T的频率在T1DM患者和对照组中存在差异(cp = 0.0065),共显性(cp = 0.026)和隐性(cp = 0.015)模式也存在差异。T1DM患者HLA等位基因DRB1*03 (pc < 0.0013)、DRB1*04 (cp = 0.0169)、DQA1*03 (cp = 0.0222)、DQA1*05 (cp < 0.0006)、DQB1*02 (cp = 0.0005)、DQB1*06 (cp < 0.0005)的频率增高。DRB1*07 (cp = 0.0078)、DRB1*11 (cp = 0.0013)、DRB1*13 (cp < 0.0364)、DRB1*15 (cp < 0.0013)、DQA1*01 (cp < 0.0006)、DQA1*02 (cp = 0.0348)的频率较低。DRB1: DQA1: DQB1单倍型的频率较高,包括03:05:02 (p < 0.0001)和04:03:03 (p = 0.0017),而其他单倍型的频率较低,包括07:02:02 (p = 0.0032)、11:05:03 (p = 0.0007)和15:01:06 (p = 0.0002)。以上HLA单倍型rs2070874 C/C的分层在T1DM患者和对照组之间没有显著差异。然而,当对HLA易感单倍型(03:05:02/04:03:03)进行分层时,T1DM开始于≤13岁的年轻患者具有更高的SNP频率(rs2070874 C/C);与低IL-4产生相关的基因(p < 0.024)。结论在携带HLA易感等位基因/单倍型的年轻人中,携带rs2070874 C/C基因型(与IL-4的低产生相关)会增加T1DM的风险。
{"title":"Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens","authors":"A. Osman, I. Brema, Alaa AlQurashi, A. Al-jurayyan, Benjamin Bradley, Muaawia Hamza","doi":"10.1177/03946320221090330","DOIUrl":"https://doi.org/10.1177/03946320221090330","url":null,"abstract":"Introduction Type 1 diabetes mellitus (T1DM) is characterized by autoimmune destruction of insulin-producing pancreatic beta (β-) cells. Previous studies suggested an imbalance between and pro- and anti-inflammatory cytokines exacerbates T1DM development. Objectives We aimed to test the hypothesis that patients with T1DM carry a higher frequency of regulatory genes associated with low levels of the anti-inflammatory cytokines interleukin-4 (IL-4), its receptor (IL-4R), and interleukin-10 (IL-10). Methods Accordingly, we compared frequencies of five different single nucleotide polymorphisms (SNPs) in T1DM patients and healthy controls who had been typed for HLA-DRB1, HLA-DQA1, and HLA-DQB1 genes. Results The frequencies of rs2070874 (IL-4) alleles C and T differed between T1DM patients and controls (cp = 0.0065), as did their codominant (cp = 0.026) and recessive (cp = 0.015) models. Increased frequencies were observed in T1DM patients for HLA alleles: DRB1*03 (pc < 0.0013), DRB1*04 (cp = 0.0169), DQA1*03 (cp = 0.0222), DQA1*05 (cp < 0.0006), DQB1*02 (cp = 0.0005), and DQB1*06 (cp < 0.0005). And lower frequencies were observed for: DRB1*07 (cp = 0.0078), DRB1*11 (cp = 0.0013), DRB1*13 (cp < 0.0364), DRB1*15 (cp < 0.0013), DQA1*01 (cp < 0.0006), and DQA1*02 (cp = 0.0348). Certain DRB1: DQA1: DQB1 haplotypes showed greater frequencies, including, 03:05:02 (p < 0.0001) and 04:03:03 (p = 0.0017), whereas others showed lower frequencies, including, 07:02:02 (p = 0.0032), 11:05:03 (p = 0.0007), and 15:01:06 (p = 0.0002). Stratification for the above HLA haplotypes with rs2070874 C/C exhibited no significant differences between T1DM patients overall and controls. However, when stratified for the vulnerable HLA haplotype (03:05:02/04:03:03), young patients in whom T1DM began at ≤13 years had a higher frequency of the SNP (rs2070874 C/C); a gene associated with low IL-4 production (p < 0.024). Conclusion This study suggests that possession of the rs2070874 C/C genotype, which is associated with low production of IL-4, increases the risk of T1DM in young individuals carrying vulnerable HLA alleles/haplotypes.","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41917862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A new indicator: The diagnostic value of CD8+T/B lymphocyte ratio in sepsis progression. CD8+T/B淋巴细胞比值在脓毒症进展中的诊断价值。
IF 3.5 3区 医学 Q3 IMMUNOLOGY Pub Date : 2022-01-01 DOI: 10.1177/03946320221123164
Yizhi Peng, Xiaofan Wang, Sheng Yin, Min Wang

Objective: To reveal the value of single lymphocyte subpopulation and their ratios in the progression of sepsis.

Methods: From January 2019 to March 2021, 39 sepsis patients, 16 septic shock patients, and 50 healthy volunteers were recruited in the Second Xiangya Hospital for this cross-sectional study. The absolute quantitation of CD4+T, CD8+T, B lymphocytes, and NK cells in peripheral blood were determined by flow cytometry. SPSS Software was used to analyze the results.

Results: On the whole, the numbers of lymphocytes in the sepsis group and in the septic shock group were lower than that in the healthy control group. Surprisingly, the percentage of CD8+T lymphocytes in the septic shock group was slightly higher than that in the sepsis group. The percentage of B lymphocytes in the sepsis group was higher than that in the healthy control group. The AUC of CD8+T/B was 0.724, with the sensitivity and specificity being 75.00% and 71.79%, respectively.

Conclusion: The immune expression pattern of patients with sepsis was not a simple decrease in the number of lymphocytes. The change in the ratios of lymphocyte subpopulation might be more meaningful along the development and progression of sepsis. The ratio of CD8+T/B could be used to diagnose the progression of sepsis and reduce the misdiagnosis rate to a certain extent.

目的:探讨单淋巴细胞亚群及其比值在脓毒症进展中的价值。方法:选取湘雅第二医院2019年1月至2021年3月39例败血症患者、16例感染性休克患者和50名健康志愿者进行横断面研究。采用流式细胞术测定外周血CD4+T、CD8+T、B淋巴细胞和NK细胞的绝对定量。采用SPSS软件对结果进行分析。结果:脓毒症组和脓毒性休克组的淋巴细胞数量总体上低于健康对照组。令人惊讶的是,感染性休克组的CD8+T淋巴细胞百分比略高于败血症组。脓毒症组B淋巴细胞百分比高于健康对照组。CD8+T/B的AUC为0.724,敏感性75.00%,特异性71.79%。结论:脓毒症患者的免疫表达模式不是简单的淋巴细胞数量减少。淋巴细胞亚群比例的变化可能在脓毒症的发生和发展过程中更有意义。CD8+T/B比值可用于诊断脓毒症的进展,在一定程度上降低误诊率。
{"title":"A new indicator: The diagnostic value of CD8+T/B lymphocyte ratio in sepsis progression.","authors":"Yizhi Peng,&nbsp;Xiaofan Wang,&nbsp;Sheng Yin,&nbsp;Min Wang","doi":"10.1177/03946320221123164","DOIUrl":"https://doi.org/10.1177/03946320221123164","url":null,"abstract":"<p><strong>Objective: </strong>To reveal the value of single lymphocyte subpopulation and their ratios in the progression of sepsis.</p><p><strong>Methods: </strong>From January 2019 to March 2021, 39 sepsis patients, 16 septic shock patients, and 50 healthy volunteers were recruited in the Second Xiangya Hospital for this cross-sectional study. The absolute quantitation of CD4+T, CD8+T, B lymphocytes, and NK cells in peripheral blood were determined by flow cytometry. SPSS Software was used to analyze the results.</p><p><strong>Results: </strong>On the whole, the numbers of lymphocytes in the sepsis group and in the septic shock group were lower than that in the healthy control group. Surprisingly, the percentage of CD8+T lymphocytes in the septic shock group was slightly higher than that in the sepsis group. The percentage of B lymphocytes in the sepsis group was higher than that in the healthy control group. The AUC of CD8+T/B was 0.724, with the sensitivity and specificity being 75.00% and 71.79%, respectively.</p><p><strong>Conclusion: </strong>The immune expression pattern of patients with sepsis was not a simple decrease in the number of lymphocytes. The change in the ratios of lymphocyte subpopulation might be more meaningful along the development and progression of sepsis. The ratio of CD8+T/B could be used to diagnose the progression of sepsis and reduce the misdiagnosis rate to a certain extent.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"36 ","pages":"3946320221123164"},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8a/13/10.1177_03946320221123164.PMC9421217.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33445090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Activation of STAT6 by intranasal allergens correlated with the development of eosinophilic chronic rhinosinusitis in a mouse model. 在小鼠模型中,鼻内过敏原激活STAT6与嗜酸性慢性鼻窦炎的发展相关。
IF 3.5 3区 医学 Q3 IMMUNOLOGY Pub Date : 2022-01-01 DOI: 10.1177/03946320221109529
Hongqi Wei, Longjiang Xu, Peng Sun, Hongyu Xing, Zhengwen Zhu, Jisheng Liu

Eosinophilic chronic rhinosinusitis (ECRS) is a chronic inflammatory disease characterized by prominent eosinophilic infiltration along with a T-helper-2 (Th2) response. It has been well documented that signal transducer and activator of transcription 6 (STAT6) is a nuclear transcription factor that mediates Th2-type immunity and is implicatory of STAT1 and STAT3 in the pathogenesis of allergic airway diseases. However, little is known about the association between STATs and ECRS. Here, we explored the relationship between STAT1, STAT3, and/or STAT6 and eosinophilic inflammation accompanied by Th2-type immunity in a mouse model of ECRS. An ovalbumin (OVA)-staphylococcal enterotoxin B (SEB)-induced ECRS murine model was first established. The mucosal histological alterations were determined using hematoxylin and eosin staining. The number of eosinophils in peripheral blood was measured using a blood cell analyzer. The cytokine (IL-4, IL-5, IL17 A and IFN-γ) expression levels in the sinonasal mucosa and total and OVA-specific IgE from serum were measured using ELISA. Then, the protein levels of STAT1, STAT3, STAT6, phosphorylated STAT1 (p-STAT1), p-STAT3, p-STAT6, T-box expressed in T-cells (T-bet), GATA binding protein 3 (GATA-3), and retinoic acid receptor-related orphan receptor γ (RORγt) in the sinonasal mucosa were examined by immunohistochemical staining or Western blotting. Local administration of OVA combined with SEB (OVA + SEB) induced multiple polyp-like lesions, accompanied by prominent eosinophilic infiltration in the sinonasal mucosa. The OVA- and OVA+SEB-treated groups showed significantly higher eosinophil counts from peripheral blood and total and OVA-specific IgE levels from serum than those in the PBS- and SEB-treated groups. The levels of p-STAT6 were markedly increased by OVA + SEB exposure, as well as GATA-3, IL-4, and IL-5, but did not affect STAT6, p-STAT1, p-STAT3, T-bet, RORγt, IFN-γ, or IL-17A. Furthermore, an eosinophil count in the sinonasal mucosa showed a positive correlation with the level of p-STAT6 in the ECRS mouse model. Signal transducer and activator of transcription 6 signaling could be activated in the OVA+SEB-induced ECRS model and might be a crucial signal transducer in the development of Th2-skewed ECRS.

嗜酸性慢性鼻窦炎(ECRS)是一种慢性炎症性疾病,其特征是显著的嗜酸性浸润伴t -辅助性2 (Th2)反应。已有文献表明,转录信号换能器和激活因子6 (STAT6)是一种介导th2型免疫的核转录因子,STAT1和STAT3在变应性气道疾病的发病机制中具有重要意义。然而,人们对STATs和ECRS之间的关系知之甚少。在此,我们在小鼠ECRS模型中探讨了STAT1、STAT3和/或STAT6与伴有th2型免疫的嗜酸性粒细胞炎症之间的关系。首次建立卵清蛋白(OVA)-葡萄球菌肠毒素B (SEB)诱导的小鼠ECRS模型。采用苏木精和伊红染色测定粘膜组织学改变。用血细胞分析仪测定外周血中嗜酸性粒细胞的数量。采用ELISA法检测鼻窦黏膜细胞因子(IL-4、IL-5、il - 17 A、IFN-γ)表达水平及血清总IgE和ova特异性IgE水平。然后,采用免疫组化染色或Western blotting检测鼻窦黏膜中STAT1、STAT3、STAT6、磷酸化STAT1 (p-STAT1)、p-STAT3、p-STAT6、t细胞中表达的T-box (T-bet)、GATA结合蛋白3 (GATA-3)和视黄酸受体相关孤儿受体γ (RORγt)的蛋白水平。局部给药OVA联合SEB (OVA + SEB)诱导多发性息肉样病变,鼻黏膜伴明显嗜酸性粒细胞浸润。与PBS和seb处理组相比,OVA-和OVA+ seb处理组外周血嗜酸性粒细胞计数、血清总IgE和OVA特异性IgE水平显著高于PBS和seb处理组。暴露于OVA + SEB后,p-STAT6以及GATA-3、IL-4和IL-5的水平显著升高,但对STAT6、p-STAT1、p-STAT3、T-bet、RORγt、IFN-γ或IL-17A没有影响。此外,在ECRS小鼠模型中,鼻黏膜嗜酸性粒细胞计数与p-STAT6水平呈正相关。在OVA+ seb诱导的ECRS模型中,转录6信号转导因子和激活因子被激活,可能是th2偏斜ECRS发展的关键信号转导因子。
{"title":"Activation of STAT6 by intranasal allergens correlated with the development of eosinophilic chronic rhinosinusitis in a mouse model.","authors":"Hongqi Wei,&nbsp;Longjiang Xu,&nbsp;Peng Sun,&nbsp;Hongyu Xing,&nbsp;Zhengwen Zhu,&nbsp;Jisheng Liu","doi":"10.1177/03946320221109529","DOIUrl":"https://doi.org/10.1177/03946320221109529","url":null,"abstract":"<p><p>Eosinophilic chronic rhinosinusitis (ECRS) is a chronic inflammatory disease characterized by prominent eosinophilic infiltration along with a T-helper-2 (Th2) response. It has been well documented that signal transducer and activator of transcription 6 (STAT6) is a nuclear transcription factor that mediates Th2-type immunity and is implicatory of STAT1 and STAT3 in the pathogenesis of allergic airway diseases. However, little is known about the association between STATs and ECRS. Here, we explored the relationship between STAT1, STAT3, and/or STAT6 and eosinophilic inflammation accompanied by Th2-type immunity in a mouse model of ECRS. An ovalbumin (OVA)-staphylococcal enterotoxin B (SEB)-induced ECRS murine model was first established. The mucosal histological alterations were determined using hematoxylin and eosin staining. The number of eosinophils in peripheral blood was measured using a blood cell analyzer. The cytokine (IL-4, IL-5, IL17 A and IFN-γ) expression levels in the sinonasal mucosa and total and OVA-specific IgE from serum were measured using ELISA. Then, the protein levels of STAT1, STAT3, STAT6, phosphorylated STAT1 (p-STAT1), p-STAT3, p-STAT6, T-box expressed in T-cells (T-bet), GATA binding protein 3 (GATA-3), and retinoic acid receptor-related orphan receptor γ (RORγt) in the sinonasal mucosa were examined by immunohistochemical staining or Western blotting. Local administration of OVA combined with SEB (OVA + SEB) induced multiple polyp-like lesions, accompanied by prominent eosinophilic infiltration in the sinonasal mucosa. The OVA- and OVA+SEB-treated groups showed significantly higher eosinophil counts from peripheral blood and total and OVA-specific IgE levels from serum than those in the PBS- and SEB-treated groups. The levels of p-STAT6 were markedly increased by OVA + SEB exposure, as well as GATA-3, IL-4, and IL-5, but did not affect STAT6, p-STAT1, p-STAT3, T-bet, RORγt, IFN-γ, or IL-17A. Furthermore, an eosinophil count in the sinonasal mucosa showed a positive correlation with the level of p-STAT6 in the ECRS mouse model. Signal transducer and activator of transcription 6 signaling could be activated in the OVA+SEB-induced ECRS model and might be a crucial signal transducer in the development of Th2-skewed ECRS.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":" ","pages":"3946320221109529"},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/04/aa/10.1177_03946320221109529.PMC9218454.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40122485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
PM2.5 activated NLRP3 inflammasome and IL-1β release in MH-S cells by facilitating autophagy via activating Wnt5a. PM2.5通过激活Wnt5a促进自噬,激活MH-S细胞的NLRP3炎性体和IL-1β释放。
IF 3.5 3区 医学 Q3 IMMUNOLOGY Pub Date : 2022-01-01 DOI: 10.1177/03946320221137464
Guanli Yuan, Yinfeng Liu, Zheng Wang, Xiaotong Wang, Zhuoxiao Han, Xixin Yan, Aihong Meng

Particulate matter 2.5 (PM2.5)-induced pulmonary inflammation is an important issue worldwide. NLRP3 inflammasome activation has been found to be involved in pulmonary inflammation development. However, whether PM2.5 induces pulmonary inflammation by activating the NLRP3 inflammasome has not yet been fully elucidated. This study researched whether PM2.5 induces the NLRP3 inflammasomes activation to trigger pulmonary inflammation.Mice and MH-S cells were exposed to PM2.5, BOX5, and Rapamycin. Hematoxylin and eosin staining was performed on the lung tissues of mice. M1 macrophage marker CD80 expression in the lung tissues of mice and LC3B expression in MH-S cells was detected by immunofluorescence. IL-1β level in the lavage fluid and MH-S cells were detected by enzyme-linked immunosorbent assay. Protein expression was detected by Western blot. Autophagy assay in MH-S cells was performed by LC3B-GFP punctae experiment.PM2.5 exposure induced the lung injury of mice and increased NLRP3, P62, Wnt5a, LC3BII/I, and CD80 expression and IL-1β release in the lung tissues. PM2.5 treatment increased NLRP3, pro-caspase-1, cleaved caspase-1, Pro-IL-1β, Pro-IL-18, P62, LC3BII/I, and Wnt5a expression, IL-1β release, and LC3B-GFP punctae in MH-S cells. However, BOX5 treatment counteracted this effect of PM2.5 on lung tissues of mice and MH-S cells. Rapamycin reversed the effect of BOX5 on PM2.5-induced lung tissues of mice and MH-S cells.PM2.5 activated the NLRP3 inflammasome and IL-1β release in MH-S cells by facilitating the autophagy via activating Wnt5a. The findings of this study provided a new clue for the treatment of pulmonary inflammation caused by PM2.5.

颗粒物质2.5 (PM2.5)引起的肺部炎症是一个全球性的重要问题。NLRP3炎性体活化已被发现参与肺部炎症的发展。然而,PM2.5是否通过激活NLRP3炎性体诱导肺部炎症尚未完全阐明。本研究研究PM2.5是否诱导NLRP3炎性小体激活从而引发肺部炎症。小鼠和MH-S细胞暴露于PM2.5、BOX5和雷帕霉素。对小鼠肺组织进行苏木精、伊红染色。免疫荧光法检测小鼠肺组织中M1巨噬细胞标志物CD80的表达和MH-S细胞中LC3B的表达。采用酶联免疫吸附法检测灌洗液和MH-S细胞中IL-1β水平。Western blot检测蛋白表达。pm2.5暴露诱导小鼠肺组织NLRP3、P62、Wnt5a、LC3BII/I、CD80表达增加,IL-1β释放增加。PM2.5处理增加了MH-S细胞NLRP3、pro-caspase-1、cleaved caspase-1、Pro-IL-1β、Pro-IL-18、P62、LC3BII/I和Wnt5a的表达、IL-1β的释放和LC3B-GFP点。然而,BOX5处理抵消了PM2.5对小鼠肺组织和MH-S细胞的这种影响。雷帕霉素逆转了BOX5对pm2.5诱导的小鼠肺组织和MH-S细胞的影响,pm2.5通过激活Wnt5a促进MH-S细胞自噬,从而激活NLRP3炎性体和IL-1β的释放。本研究结果为PM2.5引起的肺部炎症的治疗提供了新的线索。
{"title":"PM2.5 activated NLRP3 inflammasome and IL-1β release in MH-S cells by facilitating autophagy via activating Wnt5a.","authors":"Guanli Yuan,&nbsp;Yinfeng Liu,&nbsp;Zheng Wang,&nbsp;Xiaotong Wang,&nbsp;Zhuoxiao Han,&nbsp;Xixin Yan,&nbsp;Aihong Meng","doi":"10.1177/03946320221137464","DOIUrl":"https://doi.org/10.1177/03946320221137464","url":null,"abstract":"<p><p>Particulate matter 2.5 (PM2.5)-induced pulmonary inflammation is an important issue worldwide. NLRP3 inflammasome activation has been found to be involved in pulmonary inflammation development. However, whether PM2.5 induces pulmonary inflammation by activating the NLRP3 inflammasome has not yet been fully elucidated. This study researched whether PM2.5 induces the NLRP3 inflammasomes activation to trigger pulmonary inflammation.Mice and MH-S cells were exposed to PM2.5, BOX5, and Rapamycin. Hematoxylin and eosin staining was performed on the lung tissues of mice. M1 macrophage marker CD80 expression in the lung tissues of mice and LC3B expression in MH-S cells was detected by immunofluorescence. IL-1β level in the lavage fluid and MH-S cells were detected by enzyme-linked immunosorbent assay. Protein expression was detected by Western blot. Autophagy assay in MH-S cells was performed by LC3B-GFP punctae experiment.PM2.5 exposure induced the lung injury of mice and increased NLRP3, P62, Wnt5a, LC3BII/I, and CD80 expression and IL-1β release in the lung tissues. PM2.5 treatment increased NLRP3, pro-caspase-1, cleaved caspase-1, Pro-IL-1β, Pro-IL-18, P62, LC3BII/I, and Wnt5a expression, IL-1β release, and LC3B-GFP punctae in MH-S cells. However, BOX5 treatment counteracted this effect of PM2.5 on lung tissues of mice and MH-S cells. Rapamycin reversed the effect of BOX5 on PM2.5-induced lung tissues of mice and MH-S cells.PM2.5 activated the NLRP3 inflammasome and IL-1β release in MH-S cells by facilitating the autophagy via activating Wnt5a. The findings of this study provided a new clue for the treatment of pulmonary inflammation caused by PM2.5.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":" ","pages":"3946320221137464"},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c4/88/10.1177_03946320221137464.PMC9647284.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40672611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Biomarkers of inflammation and left ventricular remodelling in psoriasis patients treated with infliximab. 英夫利昔单抗治疗银屑病患者炎症和左心室重构的生物标志物。
IF 3.5 3区 医学 Q3 IMMUNOLOGY Pub Date : 2022-01-01 DOI: 10.1177/03946320221111131
Helga Midtbø, Ester Kringeland, Eva Gerdts, Per Magne Ueland, Klaus Meyer, Anja Linde, Arve Ulvik, Roland Jonsson, Kåre Steinar Tveit

Objective: Psoriasis is an immune mediated disorder associated with T cell activation and cardiovascular disease (CVD). We explored the association of inflammation with left ventricular (LV) remodelling in psoriasis patients receiving treatment with the tumour necrosis factor-α (TNF-α) blocker infliximab. Methods: Psoriasis patients (n = 47, age 47 ± 14 years, 66% men) and 99 control subjects without psoriasis (age 47 ± 11 years, 72% men) were examined by echocardiography in a cross-sectional study. LV remodelling was assessed by LV mass index for height in the allometric power of 2.7. Serum concentrations of C-reactive protein (CRP), serum amyloid A (SAA), neopterin, kynurenine:tryptophan ratio (KTR) and the pyridoxic acid ratio (PAr) index were measured. Results: Serum concentration of neopterin (p = .007) was higher in psoriasis patients, while the other inflammatory biomarkers had similar levels. LV mass index was lower in patients than controls (35.6 ± 9.6 g/m2.7 vs. 40.3 ± 9.8 g/m2.7, p = .008). In the total study population, serum SAA (β = 0.18, p = .02), KTR (β = 0.20, p = .02) and the PAr index (β = 0.26, p = .002) were all associated with higher LV mass index independent of age, sex, body mass index, hypertension, smoking, renal function and psoriasis. Also in psoriasis patients, higher SAA level (β = 0.34, p = .02), KTR (β = 0.32, p = .02) and the PAr index (β = 0.29, p = .05) were associated with higher LV mass index independent of body mass index, hypertension and diabetes. Conclusion: Higher levels of the inflammatory biomarkers SAA, KTR and the PAr index were associated with greater LV mass index in psoriasis patients, indicating a role of chronic inflammation in LV remodelling evident even during treatment with TNF-α blockers.

目的:银屑病是一种免疫介导的疾病,与T细胞活化和心血管疾病(CVD)相关。我们探讨炎症与接受肿瘤坏死因子-α (TNF-α)阻滞剂英夫利昔单抗治疗的银屑病患者左室(LV)重构的关系。方法:采用超声心动图对47例银屑病患者(年龄47±14岁,男性占66%)和99例非银屑病对照(年龄47±11岁,男性占72%)进行横断面研究。在异速幂为2.7的情况下,用LV质量指数评价LV的高度重塑。测定血清c反应蛋白(CRP)、血清淀粉样蛋白A (SAA)、新蝶呤、犬尿氨酸:色氨酸比(KTR)和吡哆酸比(PAr)指数。结果:银屑病患者血清新蝶呤浓度较高(p = .007),而其他炎症生物标志物水平相似。患者左室质量指数低于对照组(35.6±9.6 g/m2.7 vs. 40.3±9.8 g/m2.7, p = 0.008)。在整个研究人群中,血清SAA (β = 0.18, p = 0.02)、KTR (β = 0.20, p = 0.02)和PAr指数(β = 0.26, p = 0.002)均与较高的左室质量指数相关,与年龄、性别、体重指数、高血压、吸烟、肾功能和牛皮癣无关。在银屑病患者中,较高的SAA水平(β = 0.34, p = 0.02)、KTR水平(β = 0.32, p = 0.02)和PAr指数(β = 0.29, p = 0.05)与较高的左室质量指数、高血压和糖尿病相关。结论:银屑病患者较高水平的炎症生物标志物SAA、KTR和PAr指数与较高的左室质量指数相关,表明慢性炎症在左室重塑中的作用明显,即使在TNF-α阻滞剂治疗期间也是如此。
{"title":"Biomarkers of inflammation and left ventricular remodelling in psoriasis patients treated with infliximab.","authors":"Helga Midtbø,&nbsp;Ester Kringeland,&nbsp;Eva Gerdts,&nbsp;Per Magne Ueland,&nbsp;Klaus Meyer,&nbsp;Anja Linde,&nbsp;Arve Ulvik,&nbsp;Roland Jonsson,&nbsp;Kåre Steinar Tveit","doi":"10.1177/03946320221111131","DOIUrl":"https://doi.org/10.1177/03946320221111131","url":null,"abstract":"<p><p><b>Objective:</b> Psoriasis is an immune mediated disorder associated with T cell activation and cardiovascular disease (CVD). We explored the association of inflammation with left ventricular (LV) remodelling in psoriasis patients receiving treatment with the tumour necrosis factor-α (TNF-α) blocker infliximab. <b>Methods:</b> Psoriasis patients (<i>n</i> = 47, age 47 ± 14 years, 66% men) and 99 control subjects without psoriasis (age 47 ± 11 years, 72% men) were examined by echocardiography in a cross-sectional study. LV remodelling was assessed by LV mass index for height in the allometric power of 2.7. Serum concentrations of C-reactive protein (CRP), serum amyloid A (SAA), neopterin, kynurenine:tryptophan ratio (KTR) and the pyridoxic acid ratio (PAr) index were measured. <b>Results:</b> Serum concentration of neopterin (<i>p</i> = .007) was higher in psoriasis patients, while the other inflammatory biomarkers had similar levels. LV mass index was lower in patients than controls (35.6 ± 9.6 g/m<sup>2.7</sup> vs. 40.3 ± 9.8 g/m<sup>2.7</sup>, <i>p</i> = .008). In the total study population, serum SAA (β = 0.18, <i>p</i> = .02), KTR (β = 0.20, <i>p</i> = .02) and the PAr index (β = 0.26, <i>p</i> = .002) were all associated with higher LV mass index independent of age, sex, body mass index, hypertension, smoking, renal function and psoriasis. Also in psoriasis patients, higher SAA level (β = 0.34, <i>p</i> = .02), KTR (β = 0.32, <i>p</i> = .02) and the PAr index (β = 0.29, <i>p</i> = .05) were associated with higher LV mass index independent of body mass index, hypertension and diabetes. <b>Conclusion:</b> Higher levels of the inflammatory biomarkers SAA, KTR and the PAr index were associated with greater LV mass index in psoriasis patients, indicating a role of chronic inflammation in LV remodelling evident even during treatment with TNF-α blockers.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":" ","pages":"3946320221111131"},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/16/10.1177_03946320221111131.PMC9379959.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40699940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evodiamine suppresses the progression of non-small cell lung carcinoma via endoplasmic reticulum stress-mediated apoptosis pathway in vivo and in vitro 吴茱萸碱通过内质网应激介导的细胞凋亡途径抑制非小细胞肺癌的体内外进展
IF 3.5 3区 医学 Q3 IMMUNOLOGY Pub Date : 2022-01-01 DOI: 10.1177/03946320221086079
Yu-ting Li, Yuming Wang, Xiaoqun Wang, Lulu Jin, Lu Yang, Jinli Zhu, Hongwu Wang, Fang Zheng, H. Cui, Xiaojiang Li, Yingjie Jia
Background Evodiamine (EVO) is one of the major components isolated from Evodia rutaecarpa (Juss.). Recent studies have shown that EVO has an anti-cancer effect. However, the pharmacological mechanism by which EVO impacts cancer is still poorly understood. Objectives This study focused on asking the anti-cancer effect of EVO in human non-small cell lung carcinoma (NSCLC), and in particular to investigate whether EVO acts via modulating the endoplasmic reticulum stress (ERS)-mediated apoptosis pathway. Materials and Methods A Lewis lung carcinoma (LLC) tumor-bearing mouse model was treated with low-dose EVO (5 mg/kg) and high-dose EVO (10 mg/kg) intraperitoneally for 14 d. The effects of EVO on tumor growth, apoptosis, and ERS were assessed. In addition, NSCLC A549 and LLC cells were treated with EVO in vitro. The effects of EVO on cell proliferation, apoptosis, and ERS were investigated. Finally, 4-phenylbutyric acid (4-PBA), an ERS inhibitor, was used to validate whether EVO induced apoptosis of NSCLC cells by modulating ERS. Results EVO treatment significantly inhibited tumor growth in LLC tumor-bearing mice. H&E staining indicated that EVO treatment reduced the number of tumor cells and the nucleo-plasmic ratio. Immunostaining showed that EVO treatment significantly decreased the expression of Ki-67. TUNEL staining revealed that EVO induced apoptosis in the tumor. Likewise, EVO treatment up-regulated the expression of apoptosis-related genes and proteins and increased activation of the ERS pathway in the tumor. Additionally, EVO inhibited cell proliferation and increased cell apoptotic rates in A549 and LLC cells. EVO also increased the expression levels of genes and proteins associated with ERS-mediated apoptosis pathway in vitro. The effects of EVO on apoptosis were abolished by 4-PBA treatment. Conclusions Our study demonstrated that EVO suppresses the progression of NSCLC by modulating the ERS-mediated apoptosis pathway.
背景:evolodiamine (EVO)是从吴茱萸(jurs .)中分离得到的主要成分之一。最近的研究表明EVO有抗癌作用。然而,EVO影响癌症的药理学机制仍然知之甚少。目的探讨EVO对人非小细胞肺癌(NSCLC)的抗癌作用,特别是EVO是否通过调节内质网应激(ERS)介导的细胞凋亡途径起作用。材料与方法采用低剂量EVO (5 mg/kg)和高剂量EVO (10 mg/kg)腹腔注射Lewis肺癌(LLC)荷瘤小鼠模型14 d,观察EVO对肿瘤生长、凋亡和ERS的影响。此外,体外用EVO处理NSCLC A549和LLC细胞。观察EVO对细胞增殖、凋亡和ERS的影响。最后,利用ERS抑制剂4-苯基丁酸(4-PBA)验证EVO是否通过调节ERS诱导NSCLC细胞凋亡。结果EVO能明显抑制LLC荷瘤小鼠的肿瘤生长。H&E染色显示EVO处理后肿瘤细胞数量减少,核质比降低。免疫染色显示EVO处理显著降低Ki-67的表达。TUNEL染色显示EVO诱导肿瘤细胞凋亡。同样,EVO处理上调了肿瘤中凋亡相关基因和蛋白的表达,增加了ERS通路的激活。此外,EVO还能抑制A549和LLC细胞的增殖,增加细胞凋亡率。EVO还增加了体外ers介导的凋亡通路相关基因和蛋白的表达水平。4-PBA可消除EVO对细胞凋亡的影响。结论EVO通过调节ers介导的凋亡通路抑制NSCLC的进展。
{"title":"Evodiamine suppresses the progression of non-small cell lung carcinoma via endoplasmic reticulum stress-mediated apoptosis pathway in vivo and in vitro","authors":"Yu-ting Li, Yuming Wang, Xiaoqun Wang, Lulu Jin, Lu Yang, Jinli Zhu, Hongwu Wang, Fang Zheng, H. Cui, Xiaojiang Li, Yingjie Jia","doi":"10.1177/03946320221086079","DOIUrl":"https://doi.org/10.1177/03946320221086079","url":null,"abstract":"Background Evodiamine (EVO) is one of the major components isolated from Evodia rutaecarpa (Juss.). Recent studies have shown that EVO has an anti-cancer effect. However, the pharmacological mechanism by which EVO impacts cancer is still poorly understood. Objectives This study focused on asking the anti-cancer effect of EVO in human non-small cell lung carcinoma (NSCLC), and in particular to investigate whether EVO acts via modulating the endoplasmic reticulum stress (ERS)-mediated apoptosis pathway. Materials and Methods A Lewis lung carcinoma (LLC) tumor-bearing mouse model was treated with low-dose EVO (5 mg/kg) and high-dose EVO (10 mg/kg) intraperitoneally for 14 d. The effects of EVO on tumor growth, apoptosis, and ERS were assessed. In addition, NSCLC A549 and LLC cells were treated with EVO in vitro. The effects of EVO on cell proliferation, apoptosis, and ERS were investigated. Finally, 4-phenylbutyric acid (4-PBA), an ERS inhibitor, was used to validate whether EVO induced apoptosis of NSCLC cells by modulating ERS. Results EVO treatment significantly inhibited tumor growth in LLC tumor-bearing mice. H&E staining indicated that EVO treatment reduced the number of tumor cells and the nucleo-plasmic ratio. Immunostaining showed that EVO treatment significantly decreased the expression of Ki-67. TUNEL staining revealed that EVO induced apoptosis in the tumor. Likewise, EVO treatment up-regulated the expression of apoptosis-related genes and proteins and increased activation of the ERS pathway in the tumor. Additionally, EVO inhibited cell proliferation and increased cell apoptotic rates in A549 and LLC cells. EVO also increased the expression levels of genes and proteins associated with ERS-mediated apoptosis pathway in vitro. The effects of EVO on apoptosis were abolished by 4-PBA treatment. Conclusions Our study demonstrated that EVO suppresses the progression of NSCLC by modulating the ERS-mediated apoptosis pathway.","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44226776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations. 异柠檬酸脱氢酶-1和肿瘤蛋白53突变胶质瘤基因组和转录谱的综合分析。
IF 3.5 3区 医学 Q3 IMMUNOLOGY Pub Date : 2022-01-01 DOI: 10.1177/03946320221139262
Han-Qing Liu, Wei-Xin Li, Ya-Wen An, Tao Wu, Guang-Yu Jiang, Yu Dong, Wei-Xin Chen, Jian-Chun Wang, Cheng Wang, Shuo Song

Background: The gene mutation of isocitrate dehydrogenase-1 (IDH1) is commonly found in LGG and some GBM patients and usually carries tumor protein 53 (TP53) mutations. However, the underlying mechanisms on both mutations of glioma patients in IDH1 and TP53 are still unclear. Aim: To find the potential target markers in GBM and LGG patients with IDH1 and TP53 mutation.Method: A total of 1122 glioma patients from The Cancer Genome Atlas were enrolled and divided as wild-type (without IDH1 and TP53 mutations) or both mutant (both IDH1 and TP53 mutations). The data of clinicopathological characteristics, mRNA, mutations, and copy number alteration were analyzed. Results: IDH1 and TP53 mutations, not gene expression, affect the survival probability of GBM and LGG patients, which might be related to neuron function, immune function, tumor invasion, and metastasis. The effects of the selected gene (EMILIN3, SAA1, VSTM2A, HAMP, IFT80, and CHIC2) on glioma patients could be regulated by IDH1 and TP53 mutations and had a higher survival possibility in these patients. Conclusions: The selected genes in GBM and LGG patients with IDH1 and TP53 mutations could be a potential prognosis marker in the future.

背景:异柠檬酸脱氢酶-1 (IDH1)基因突变常见于LGG和部分GBM患者,通常携带肿瘤蛋白53 (TP53)突变。然而,胶质瘤患者IDH1和TP53突变的潜在机制尚不清楚。目的:寻找IDH1和TP53突变的GBM和LGG患者的潜在靶标志物。方法:选取来自The Cancer Genome Atlas的1122例胶质瘤患者,将其分为野生型(未发生IDH1和TP53突变)和双突变型(均发生IDH1和TP53突变)。分析临床病理特征、mRNA、突变、拷贝数改变等数据。结果:影响GBM和LGG患者生存率的不是基因表达,而是IDH1和TP53突变,可能与神经元功能、免疫功能、肿瘤侵袭转移有关。所选择的基因(EMILIN3、SAA1、VSTM2A、HAMP、IFT80和CHIC2)对胶质瘤患者的作用可受IDH1和TP53突变的调控,在这些患者中具有较高的生存可能性。结论:在IDH1和TP53突变的GBM和LGG患者中选择的基因可能是未来潜在的预后指标。
{"title":"Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations.","authors":"Han-Qing Liu,&nbsp;Wei-Xin Li,&nbsp;Ya-Wen An,&nbsp;Tao Wu,&nbsp;Guang-Yu Jiang,&nbsp;Yu Dong,&nbsp;Wei-Xin Chen,&nbsp;Jian-Chun Wang,&nbsp;Cheng Wang,&nbsp;Shuo Song","doi":"10.1177/03946320221139262","DOIUrl":"https://doi.org/10.1177/03946320221139262","url":null,"abstract":"<p><p><b>Background:</b> The gene mutation of isocitrate dehydrogenase-1 (IDH1) is commonly found in LGG and some GBM patients and usually carries tumor protein 53 (TP53) mutations. However, the underlying mechanisms on both mutations of glioma patients in IDH1 and TP53 are still unclear. <b>Aim:</b> To find the potential target markers in GBM and LGG patients with IDH1 and TP53 mutation.<b>Method:</b> A total of 1122 glioma patients from The Cancer Genome Atlas were enrolled and divided as wild-type (without IDH1 and TP53 mutations) or both mutant (both IDH1 and TP53 mutations). The data of clinicopathological characteristics, mRNA, mutations, and copy number alteration were analyzed. <b>Results:</b> IDH1 and TP53 mutations, not gene expression, affect the survival probability of GBM and LGG patients, which might be related to neuron function, immune function, tumor invasion, and metastasis. The effects of the selected gene (EMILIN3, SAA1, VSTM2A, HAMP, IFT80, and CHIC2) on glioma patients could be regulated by IDH1 and TP53 mutations and had a higher survival possibility in these patients. <b>Conclusions:</b> The selected genes in GBM and LGG patients with IDH1 and TP53 mutations could be a potential prognosis marker in the future.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":" ","pages":"3946320221139262"},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bb/2e/10.1177_03946320221139262.PMC9669701.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40488058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Immunopathology and Pharmacology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1